Search

everythinglearnresearchcommunity

for

Search:↓

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

A rare scalp tumor was removed from a 49-year-old woman, with a good outlook if benign but needing careful monitoring if malignant.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Tridax procumbens may boost the immune system.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Remembering to take PrEP is the main challenge, and urine monitoring is a preferred adherence method.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Topical rapamycin may effectively treat fibrous papules on the face.

Antioxidants can block the cancer-fighting effects of doxorubicin.

The FDA approved a new Pfizer drug for hair loss in teens.